Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dual molecules as new antimalarials.

Xavier J Salom-Roig1, Abdallah Hamzé, Michèle Calas

  • 1CNRS UMR 5810, Université de Montpellier II, CP 22, Place Eugène Bataillon, F- 34095 Montpellier Cedex 5, France.

Combinatorial Chemistry & High Throughput Screening
|February 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mild PIFA-mediated synthesis of benzo[4,5]thiazolo[3,2-<i>a</i>]indoles <i>via</i> oxidative cyclization.

Organic & biomolecular chemistry·2026
Same author

Who's who in the field of combretastatin A4 analogues: ?

European journal of medicinal chemistry·2026
Same author

Mechanochemical Approach for Metal-Free Regioselective C5-Sulfenylation of Imidazo[2,1-b]Thiazoles.

ChemSusChem·2025
Same author

Recent Advancements in the Development of HDAC/Tubulin Dual-Targeting Inhibitors.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

β-Glucuronidase-Responsive Albumin-Binding Prodrug of Colchicine-Site Binders for Selective Cancer Therapy.

ChemMedChem·2025
Same author

1,1'-Diarylethylene as a Key Additive for the Visible Light Synthesis of Bioactive Dihydrobenzo[<i>a</i>]phenanthridine Compounds.

The Journal of organic chemistry·2024
Same journal

Exploring Spectral Graph Theory in Combinatorial Chemistry.

Combinatorial chemistry & high throughput screening·2026
Same journal

Unveiling the Cellular and Molecular Insights into Ulcerative Colitis Pathogenesis through Integrative Multi-omics and Functional Experiments.

Combinatorial chemistry & high throughput screening·2026
Same journal

Integrated Multi-Omics Identification of Novel Diagnostic Biomarkers and Immunometabolic Therapeutic Targets in Osteoporosis via Machine Learning.

Combinatorial chemistry & high throughput screening·2026
Same journal

Exploration and Prospects of Core Research Hotspots in the Mechanisms of Traditional Chinese Medicine for Treating Digestive System Malignancies Based on Bibliometrics.

Combinatorial chemistry & high throughput screening·2026
Same journal

Investigating the Potential Pharmacological Mechanisms of Huangqi in Allergic Rhinitis Using Network Pharmacology and Molecular Docking Strategies.

Combinatorial chemistry & high throughput screening·2026
Same journal

DNMT3A-driven Clonal Expansion of Hematopoiesis Influences Autoimmunity Mediated by Distinct Immune Cell Populations: A Mendelian Randomization Study.

Combinatorial chemistry & high throughput screening·2026
See all related articles

New antimalarial drugs targeting phospholipid metabolism show potent activity against resistant malaria strains. These dual-action compounds are effective in vivo and hold promise for new drug development.

Area of Science:

  • Medicinal Chemistry
  • Parasitology
  • Pharmacology

Background:

  • Malaria remains a significant global health threat, driven by drug-resistant Plasmodium falciparum strains.
  • Existing antimalarial therapies face challenges with resistance and toxicity.
  • Novel pharmacological targets are crucial for developing effective malaria treatments.

Purpose of the Study:

  • To develop a new class of antimalarial drugs by inhibiting plasmodial phospholipid metabolism.
  • To design and synthesize compounds that mimic choline and inhibit phosphatidylcholine biosynthesis.
  • To evaluate the efficacy of these novel compounds against various malaria models.

Main Methods:

  • Rational drug design of three generations of compounds: bisquaternary ammonium salts, bis-amidines, and bis-thiazolium salts/prodrugs.

Related Experiment Videos

  • In vitro testing for antimalarial activity, including IC50 determination against Plasmodium falciparum.
  • In vivo efficacy studies in Plasmodium vinckei-infected mice and primate models (P. falciparum, P. cynomolgi).
  • Investigation of drug accumulation in infected erythrocytes and interaction with malarial pigment.

    • Main Results:

    • Bisquaternary ammonium salts and bis-amidines demonstrated potent antimalarial activity with IC50 in the nanomolar range.
    • Third-generation thiazolium compounds and prodrugs were effective against multiresistant Plasmodium falciparum.
    • Compounds showed high in vivo efficacy in mouse models (ED50 < 0.2 mg/kg) and primate models, achieving cures with single doses.
    • Compounds accumulate in infected erythrocytes and exhibit dual toxicity, enhancing antimalarial effects.

    Conclusions:

    • A novel class of antimalarial agents targeting phospholipid metabolism has been successfully developed.
    • These compounds exhibit potent, rapid, and broad-spectrum activity against malaria parasites, including resistant strains.
    • The dual mechanism of action and favorable pharmacokinetic properties suggest significant potential for these molecules as new antimalarial drugs.